Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Proper inference from Simon's two-stage designs.

Koyama T, Chen H.

Stat Med. 2008 Jul 20;27(16):3145-54.

PMID:
17960777
2.

Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs.

Zhao J, Yu M, Feng XP.

BMC Med Res Methodol. 2015 Jun 7;15:48. doi: 10.1186/s12874-015-0039-5.

3.

A modification of Simon's optimal design for phase II trials when the criterion is median sample size.

Hanfelt JJ, Slack RS, Gehan EA.

Control Clin Trials. 1999 Dec;20(6):555-66.

PMID:
10588296
4.

An optimal three-stage design for phase II clinical trials.

Ensign LG, Gehan EA, Kamen DS, Thall PF.

Stat Med. 1994 Sep 15;13(17):1727-36.

PMID:
7997706
5.

Optimal and minimax three-stage designs for phase II oncology clinical trials.

Chen K, Shan M.

Contemp Clin Trials. 2008 Jan;29(1):32-41. Epub 2007 May 6.

PMID:
17544337
6.

Balanced two-stage designs for phase II clinical trials.

Ye F, Shyr Y.

Clin Trials. 2007;4(5):514-24.

PMID:
17942467
7.

Curtailed two-stage designs in Phase II clinical trials.

Chi Y, Chen CM.

Stat Med. 2008 Dec 20;27(29):6175-89. doi: 10.1002/sim.3424.

PMID:
18816510
8.

Adaptive two-stage designs in phase II clinical trials.

Banerjee A, Tsiatis AA.

Stat Med. 2006 Oct 15;25(19):3382-95.

PMID:
16479547
9.

Stochastically curtailed phase II clinical trials.

Ayanlowo AO, Redden DT.

Stat Med. 2007 Mar 30;26(7):1462-72.

PMID:
16900560
10.

Optimal flexible designs in phase II clinical trials.

Chen TT, Ng TH.

Stat Med. 1998 Oct 30;17(20):2301-12.

PMID:
9819829
11.

Graphical search for two-stage designs for phase II clinical trials.

Jung SH, Carey M, Kim KM.

Control Clin Trials. 2001 Aug;22(4):367-72.

PMID:
11514038
12.

A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials.

Jin H, Wei Z.

Contemp Clin Trials. 2012 Nov;33(6):1255-60. doi: 10.1016/j.cct.2012.07.003. Epub 2012 Jul 6.

PMID:
22772088
13.

Optimal three-stage designs for phase II cancer clinical trials.

Chen TT.

Stat Med. 1997 Dec 15;16(23):2701-11.

PMID:
9421870
14.

Hypothesis testing for two-stage designs with over or under enrollment.

Zeng D, Gao F, Hu K, Jia C, Ibrahim JG.

Stat Med. 2015 Jul 20;34(16):2417-26. doi: 10.1002/sim.6490. Epub 2015 Mar 25.

15.

Optimal two-stage designs allowing flexibility in number of subjects for phase II clinical trials.

Masaki N, Koyama T, Yoshimura I, Hamada C.

J Biopharm Stat. 2009 Jul;19(4):721-31. doi: 10.1080/10543400902964167.

PMID:
20183436
16.
17.

Admissible two-stage designs for phase II cancer clinical trials.

Jung SH, Lee T, Kim K, George SL.

Stat Med. 2004 Feb 28;23(4):561-9.

PMID:
14755389
18.

Optimal adaptive two-stage designs for early phase II clinical trials.

Shan G, Wilding GE, Hutson AD, Gerstenberger S.

Stat Med. 2016 Apr 15;35(8):1257-66. doi: 10.1002/sim.6794. Epub 2015 Nov 3.

19.

What inference for two-stage phase II trials?

Porcher R, Desseaux K.

BMC Med Res Methodol. 2012 Aug 6;12:117.

20.

Alternative designs of phase II trials considering response and toxicity.

Jin H.

Contemp Clin Trials. 2007 Jul;28(4):525-31. Epub 2007 Mar 14.

PMID:
17428744

Supplemental Content

Support Center